Pre-Clinical Research

Photometics, at its facility in California, developed the cancer treatment using novel animal models co-developed with Jackson Laboratory, a leading supplier of mice for cancer research, and Sutter Health in Sacramento. The significant and compelling success demonstrated in preclinical studies led to rapid approval of the Phase 1 human trial conducted at UC Davis Medical Center.


A Phase 1 Clinical Trial of the Photometics ScanStar involving 30 human patients with basal cell carcinoma was approved by the Institutional Review Board of the University of California Davis Medical Center. The study began in November 2012 under the leadership of April Armstrong, M.D., Director of Clinical Research in Dermatology.